Home LiteratureArticle Details
PMID: 12515810 Published · ppublish English Journal Article

CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells.

The Journal of experimental medicine ·Vol. 197 ·No. 1 ·2003-01-06 ·Pages 19-26

Vacchio MS, Hodes RJ

Abstract

Whereas ligation of CD28 is known to provide a critical costimulatory signal for activation of CD4 T cells, the requirement for CD28 as a costimulatory signal during activation of CD8 cells is less well defined. Even less is known about the involvement of CD28 signals during peripheral tolerance induction in CD8 T cells. In this study, comparison of T cell responses from CD28-deficient and CD28 wild-type H-Y-specific T cell receptor transgenic mice reveals that CD8 cells can proliferate, secrete cytokines, and generate cytotoxic T lymphocytes efficiently in the absence of CD28 costimulation in vitro. Surprisingly, using pregnancy as a model to study the H-Y-specific response of maternal T cells in the presence or absence of CD28 costimulation in vivo, it was found that peripheral tolerance does not occur in CD28KO pregnants in contrast to the partial clonal deletion and hyporesponsiveness of remaining T cells observed in CD28WT pregnants. These data demonstrate for the first time that CD28 is critical for tolerance induction of CD8 T cells, contrasting markedly with CD28 independence of in vitro activation, and suggest that the role of CD28/B7 interactions in peripheral tolerance of CD8 T cells may differ significantly from that of CD4 T cells.

MeSH Terms
Animals CD28 Antigens/metabolism CD8-Positive T-Lymphocytes/cytology,immunology,metabolism Cell Division Female Flow Cytometry H-Y Antigen/immunology,metabolism Immune Tolerance Interferon-gamma/immunology,metabolism Lymphocyte Activation Male Mice Mice, Knockout Mice, Transgenic Pregnancy Receptors, Antigen, T-Cell/immunology,metabolism T-Lymphocytes, Cytotoxic/cytology,immunology,metabolism
Chemicals
CD28 Antigens H-Y Antigen Receptors, Antigen, T-Cell Interferon-gamma
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Vacchio Melanie S
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. vacchio@nih.gov
Hodes Richard J
References (36)
36 references, click to expand
  1. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.
    J Immunol. 2000 Feb 1;164(3):1216-22 PMID: 10640733
  2. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
    J Exp Med. 1995 Aug 1;182(2):459-65 PMID: 7543139
  3. Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL.
    J Immunol. 2000 Sep 15;165(6):3088-93 PMID: 10975820
  4. CTLA-4 regulates induction of anergy in vivo.
    Immunity. 2001 Feb;14(2):145-55 PMID: 11239447
  5. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
    Science. 1995 Nov 10;270(5238):985-8 PMID: 7481803
  6. B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors.
    J Immunol. 1995 Dec 1;155(11):5167-74 PMID: 7594526
  7. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
    Immunity. 1995 Nov;3(5):541-7 PMID: 7584144
  8. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance.
    Immunity. 1996 Mar;4(3):321-8 PMID: 8624822
  9. CTLA-4 ligation blocks CD28-dependent T cell activation.
    J Exp Med. 1996 Jun 1;183(6):2541-50 PMID: 8676075
  10. CD28/B7 system of T cell costimulation.
    Annu Rev Immunol. 1996;14:233-58 PMID: 8717514
  11. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.
    Immunity. 1997 Apr;6(4):411-7 PMID: 9133420
  12. Role of interleukin 12 and costimulators in T cell anergy in vivo.
    J Exp Med. 1997 Oct 6;186(7):1119-28 PMID: 9314560
  13. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens.
    Immunity. 1998 Feb;8(2):265-74 PMID: 9492007
  14. Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft".
    J Immunol. 1998 Apr 1;160(7):3086-90 PMID: 9531261
  15. Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions.
    J Immunol. 1998 Apr 1;160(7):3180-7 PMID: 9531273
  16. Helper T cell differentiation is controlled by the cell cycle.
    Immunity. 1998 Aug;9(2):229-37 PMID: 9729043
  17. Mechanisms of peripheral T cell tolerance.
    Novartis Found Symp. 1998;215:5-14; discussion 14-20, 33-40 PMID: 9760568
  18. Linear differentiation of cytotoxic effectors into memory T lymphocytes.
    Science. 1999 Mar 12;283(5408):1745-8 PMID: 10073942
  19. Anergic CD8+ T cells can persist and function in vivo.
    J Immunol. 1999 Jul 1;163(1):155-64 PMID: 10384112
  20. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    J Immunol. 1999 Aug 1;163(3):1298-305 PMID: 10415027
  21. Multiple paths for activation of naive CD8+ T cells: CD4-independent help.
    J Immunol. 2001 Aug 1;167(3):1283-9 PMID: 11466344
  22. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    J Clin Invest. 2001 Sep;108(6):895-903 PMID: 11560959
  23. CTLA-4 is not required for induction of CD8(+) T cell anergy in vivo.
    J Immunol. 2001 Nov 1;167(9):4936-41 PMID: 11673499
  24. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory.
    J Immunol. 2001 Nov 15;167(10):5565-73 PMID: 11698427
  25. Role of CD28 for the generation and expansion of antigen-specific CD8(+) T lymphocytes during infection with Listeria monocytogenes.
    J Immunol. 2001 Nov 15;167(10):5620-7 PMID: 11698433
  26. CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function.
    J Exp Med. 2002 Jun 3;195(11):1407-18 PMID: 12045239
  27. Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells.
    Nature. 1988 Sep 15;335(6187):229-33 PMID: 2970593
  28. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.
    Proc Natl Acad Sci U S A. 1989 Feb;86(4):1333-7 PMID: 2465550
  29. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.
    Annu Rev Immunol. 1989;7:445-80 PMID: 2653373
  30. A cell culture model for T lymphocyte clonal anergy.
    Science. 1990 Jun 15;248(4961):1349-56 PMID: 2113314
  31. Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production.
    Science. 1991 Mar 8;251(4998):1228-31 PMID: 1900952
  32. The role of the CD28 receptor during T cell responses to antigen.
    Annu Rev Immunol. 1993;11:191-212 PMID: 8386518
  33. Differential T cell costimulatory requirements in CD28-deficient mice.
    Science. 1993 Jul 30;261(5121):609-12 PMID: 7688139
  34. A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes.
    J Immunol. 1994 Feb 15;152(4):1709-17 PMID: 8120380
  35. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL.
    Immunity. 1995 Jul;3(1):87-98 PMID: 7621080
  36. The roles of CD28 and CD40 ligand in T cell activation and tolerance.
    J Immunol. 2000 May 1;164(9):4465-70 PMID: 10779746
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2003-01-06
Pages
19-26
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2193800
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com